B Cell Lymphoma Survival Rate and Life Expectancy: Revised International Prognostic Index

B cell lymphoma is not one disease but a few dozen heterogeneous diseases, or individual cancers, that affect the b-cells in the lymphatic system. However, the most common type of b cell lymphoma is diffuse large b-cell lymphoma (DLBCL), and researchers have come up with a rather handy method of determining prognosis for people with DLBCL ( Diffuse Large B Cell Lymphoma life expectancy). The method is known by its initials, the R-IPI, which stands for the Revised International Prognostic Index.

The R-IPI works by identifying a specific patient group—those who have been diagnosed with DLBCL and who are then treated with the R-CHOP chemotherapeutic regimen.

The R-IPI asks five questions, and assigns a point per question when called for.

  1. Is the patient younger or older than 60? If younger, 0 points. If 60 or older, 1 point.
  2. What is the patient's ECOG performance status score? [see * below]. If 0-2, 0 points. If 3-4, 1 point.
  3. Is the patient's LDH normal or elevated? If normal, 0 points. If elevated, 1 point.
  4. How many extranodal sites are involved? If no more than 1, 0 points. If 2 or more, 1 point.
  5. What stage disease? If the patient's cancer is stage I or II, 0 points. If III or IV, 1 point.

B Cell Lymphoma Life Expectancy: The R-IPI then identifies three prognostic groups according to points.

  • 0 points: Prognosis, Very good (4-year progression-free survival 94%, overall survival, 94%)
  • 1-2 points: Prognosis, Good (4-year PFS 80%, OS 79%)
  • 3-5 points: Prognosis, Poor (4-year PFS 53%, OS 55%)

The R-IPI doesn't recognize risk groups with a perceived B cell lymphoma survival rate of under 50%.

Researchers are always looking for new methods to determine survival rates, especially among b cell lymphomas, because they are so common, but readers should be aware of the limitations of these indices since each person is different and each person's cancer is also different. It is also important to note that survival does not equal a cure.

*ECOG status: This is a scale to determine how a disease affects a patient's daily life. To see what each score means, refer to this explanation offered by the National Cancer Institute.

Source: Sehn LH et al. The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP Blood

Photo: Pexels

w00001
web
lin
b cell lymphoma tretment

More Articles

More Articles

In T cell lymphoma, T lymphocytes, which are an essential part of the body's immune response, become malignant. T cell lymphomas account for about...

Lymphomatoid Papulosis (LyP) is a rare skin disorder that involves cancerous looking skin lesions. It is more than a skin condition; it is the...

In non-Hodgkin's lymphoma, you have your B-cell lymphomas and you have your T-cell lymphomas.

Why B...

MALT lymphoma is a rare B-cell non-Hodgkin's lymphoma that typically runs an indolent or slow-growing clinical...

Mantle cell lymphoma (MCL) is a relatively rare B-cell subtype of non-Hodgkin'...

T-Cell Lymphoblastic Lymphoma (T-LBL) is a very rare subtype of non-Hodgkin's lymphoma. It tends to develop in...

In general, a diagnosis of T-cell lymphoma denotes a poorer prognosis than a diagnosis of B-cell lymphoma. One of...

Mantle cell lymphoma (MCL) is just one of 50-60 known B-cell subtypes of...

After some of the dust has settled, the thoughts of many new lymphoma patients turn to diet and nutrition. They want to know if, in the past,...

The term NK T cell lymphoma refers to one of two subtypes of lymphoma that affect the NK (Natural Killer)...

In a perfect world, every case of cancer would respond to, and be cured by first-line therapy. Unfortunately, it is not often the case. This is...

Prednisone is a glucocorticosteroid (a steroid) used in the treatment of many types of cancers. It functions as an anti-inflammatory medicine that...

In 1964, researchers at the National Cancer Institute developed the first combination chemotherapy that cured a...